Optimer Pharmaceuticals, a biotech developing anti-infective products, filed for an IPO on Thursday. Piper Jaffray and Jefferies & Company are set to manage the deal for the San Diego-based company. Terms and timing have yet to be announced.
Optimer Pharmaceuticals, a biotech developing anti-infective products, filed for an IPO on Thursday. Piper Jaffray and Jefferies & Company are set to manage the deal for the San Diego-based company. Terms and timing have yet to be announced.